Q4 2024 Earnings Call Transcript February 11, 2025 Edwards Lifesciences Corporation beats earnings expectations. Reported EPS ...

The Heart and Vascular center at Portneuf Medical Center recently marked its 400th transaortic valve replacement procedure.

Scott Ullem; Chief Financial Officer, Corporate Vice President; Edwards Lifesciences Corp Daveen Chopra; Corporate Vice President - Surgical Structural Heart; Edwards Lifesciences Corp Larry Wood; ...

will reduce the risk of complications in the future. It is likely that the indications for transcatheter aortic-valve implantation will be extended to include younger patients with less ...

The Heart Valve Devices Market is driven by advancements in aortic, mitral, tricuspid, and pulmonary valve technologies. It ...

Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.

Beyond surgical excellence, St. Elizabeth prioritizes a highly specialized and patient-focused approach to cardiac care.

We came across a bullish thesis on Edwards Lifesciences Corporation (EW) on Substack by Natan. In this article, we will ...

GlobalData’s latest report reveals that India accounted for only around 3 per cent of the market in APAC in 2024, due to ...